Identification and evolution of drug efflux pump in clinical Enterobacter aerogenes strains isolated in 1995 and 2003

PLoS ONE

Volumn 3, Issue 9, 2008, Pages

  Chevalier, Jacqueline ^a   Mulfinger, Céline ^a   Garnotel, Eric ^a,b   Nicolas, Pierre ^a,c   Davin Régil, Anne ^a   Pagès, Jean Marie ^a  

^a Aix Marseille University   (France)

^b LAVERAN MILITARY TEACHING HOSPITAL   (France)

^c SERVICE DE SANTÉ DES ARMÉES   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; BETA LACTAM ANTIBIOTIC; CEFEPIME; CHLORAMPHENICOL; CIPROFLOXACIN; EXTENDED SPECTRUM BETA LACTAMASE; IMIPENEM; NALIDIXIC ACID; NORFLOXACIN; OFLOXACIN; PORIN; QUINOLINE DERIVED ANTIINFECTIVE AGENT; SPARFLOXACIN; TETRACYCLINE; ACRA PROTEIN, E COLI; BETA LACTAMASE; CARRIER PROTEIN; ESCHERICHIA COLI PROTEIN; LIPOPROTEIN; UNCLASSIFIED DRUG;

ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIAL STRAIN; BACTERIUM IDENTIFICATION; BACTERIUM ISOLATION; CELL LEVEL; CONTROLLED STUDY; ENTEROBACTER AEROGENES; GENE MUTATION; HOSPITAL INFECTION; INFUSION PUMP; MULTIDRUG RESISTANCE; NONHUMAN; BIOLOGICAL MODEL; DRUG EFFECT; ENTEROBACTERIACEAE INFECTION; GENETICS; HUMAN; METABOLISM; MICROBIOLOGICAL EXAMINATION; MUTATION; SPECIES DIFFERENCE; TIME;

BACTERIA (MICROORGANISMS); ENTEROBACTER AEROGENES; ENTEROBACTERIACEAE; NEGIBACTERIA;

BACTERIAL TYPING TECHNIQUES; BETA-LACTAMASES; CHLORAMPHENICOL; DRUG RESISTANCE, MULTIPLE; DRUG RESISTANCE, MULTIPLE, BACTERIAL; ENTEROBACTER AEROGENES; ENTEROBACTERIACEAE INFECTIONS; ESCHERICHIA COLI PROTEINS; HUMANS; LIPOPROTEINS; MEMBRANE TRANSPORT PROTEINS; MICROBIAL SENSITIVITY TESTS; MODELS, BIOLOGICAL; MUTATION; PORINS; SPECIES SPECIFICITY; TIME FACTORS;

EID: 52449126124     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0003203     Document Type: Article

References (53)

1. Davin-Régli A, Pagès J-M (2006) Regulation of efflux pumps in Enterobacteriaceae: genetic and chemical effectors. Multiple drug resistance bacteria. 2nd edition, Carlos F. Amabile-Cuevas Editor.
2. Arpin C, Coze C, Rogues AM, Gachie JP, Bebear C, et al. (1996) Epidemiological study of an outbreak due to multidrug-resistant Enterobacter aerogenes in a medical intensive care unit. J Clin Microbiol 34: 2163-2169.
3. Davin-Régli A, Monnet D, Saux P, Bosi C, Charrel R, et al. (1996) Molecular epidemiology of Enterobacter aerogenes acquisition: one year prospective study in two intensive care units. J Clin Microbiol 34: 1474-1480.
4. Bornet C, Davin-Régli A, Bosi C, Pagès J-M, Bollet C (2000) Imipenem resistance of Enterobacter aerogenes mediated by outer membrane permeability. J Clin Microbiol 38: 1048-1052.
5. De Gheldre Y, Struelens MJ, Glupcynski Y, De Mol P, Maes N, et al. (2001) National epidemiologic surveys of Enterobacter aerogenes in Belgian hospitals from 1996 to 1998. J Clin Microbiol 39: 889-896.
6. Canton R, Oliver A, Coque TM, VarelaMdel C, Perez-Diaz JC, et al. (2002) Epidemiology of extended-spectrum beta-lactamase-producing Enterobacter isolates in a Spanish hospital during a 12-year period. J Clin Microbiol 40: 1237-1243.
7. Vonberg RP, Wolter A, Kola A, Ziesing S, Gastmeier P (2007) The endemic situation of Enterobacter aerogenes and Enterobacter cloacae: you will only discover what you are looking for. J Hosp Infect 65: 372-374.
8. Wenzel RP, Sahm DF, Thornsberry C, Draghi DC, Jones ME, Karlowsky JA (2003) In vitro susceptibilities of gram-negative bacteria isolated from hospitalized patients in four European countries, Canada, and the United States in 2000-2001 to expanded-spectrum cephalosporins and comparator antimicrobials: implications for therapy. Antimicrob Agents Chemother 47: 3089-3098.
9. Bosi C, Davin-Régli A, Bornet C, Malléa M, Pagès J-M, et al. (1999) Most Enterobacter aerogenes strains in France belong to a prevalent clone. J Clin Microbiol 37: 2165-2169.
10. Charrel RN, Pagès J-M, De Micco P, Malléa M (1996) Prevalence of outer membrane porin alteration in beta-lactam-antibiotic-resistant Enterobacter aerogenes. Antimicrob Agents Chemother 40: 2854-2858.
11. Thiolas A, Bornet C, Davin-Régli A, Pagès J-M, Bollet C (2004) Resistance to imipenem, cefepime, and cefpirome associated with mutation in Omp36 osmoporin of Enterobacter aerogenes. Biochem Biophys Res Commun 317: 851-856.
12. Thiolas A, Bollet C, La Scola B, Raoult D, Pagès J-M (2005) Successive emergence of Enterobacter aerogenes strains resistant to imipenem and colistin in a patient. Antimicrob Agents Chemother 49: 354-358.
13. Gayet S, Chollet R, Molle G, Pagès J-M, Chevalier J (2003) Modification of outer membrane protein profile and evidence suggesting an active drug pump in Enterobacter aerogenes clinical strains. Antimicrob Agents Chemother 47: 1555-1559.
14. Goshi S, Taneike I, Nagawa S, Kojio S, Tamura Y, et al. (2002) DNA analysis of nosocomial infection by Enterobacter aerogenes in three cases of septicaemia in Japan. J Hops Infect 51: 221-225.
15. Arpin C, Dubois V, Coulange L (2003) Extended-spectrum-beta-lactamase-producing Enterobacteriaceae in community and private health care centers. Antimicrob Agents Chemother 47: 3506-3514.
16. Malléa M, Chevalier J, Bornet C, Eyraud A, Davin-Régli A, et al. (1998) Porin alteration and active efflux: two in vivo drug resistance strategies used by Enterobacter aerogenes. Microbiology 144: 3003-3009.
17. Bornet C, Chollet R, Malléa M, Chevalier J, Davin-Régli A, et al. (2003) Imipenem and expression of multidrug efflux pump in Enterobacter aerogenes. Biochem Biophys Res Commun 301: 985-90.
18. Poole K (2005) Efflux-mediated antimicrobial resistance. J Antimicrob Chemother 56: 20-51.
19. Elkins CA, Nikaido H (2003) 3D structure of AcrB: the archetypal multidrug efflux transporter of Escherichia coli likely captures substrates from periplasm. Drug Resist Updat 6: 9-13.
20. Piddock LJ (2006) Clinically relevant chromosomally encoded multidrug resistance efflux pumps in bacteria. Clin Microbiol Rev 19: 382-402.
21. Pradel E, Pagès J-M (2002) The AcrAB-TolC pump contributes to multidrug resistance in the nosocomial pathogen Enterobacter aerogenes. Antimicrob Agents Chemother 46: 2640-2643.
22. Lomovskaya O, Warren MS, Lee A, Galazzo J, Fronko R, et al. (2001) Identification and characterization of inhibitors of multidrug resistance efflux pumps in Pseudomonas aeruginosa: novel agents for combination therapy. Antimicrob Agents Chemother 45: 105-116.
23. Pagès J-M, Masi M, Barbe J (2005) Inhibitors of efflux pumps in Gram-negative bacteria. Trends Mol Med 11: 382-389.
24. Malléa M, Chevalier J, Eyraud A, Pagès J-M (2002) Inhibitors of antibiotics efflux pumps in resistant Enterobacter aerogenes strains. Biochem Biophys Res Commun 293: 1370-1373.
25. Ricci V, Tzakas P, Buckley A, Piddock L J (2006) Ciprofloxacin-resistant Salmonella enterica serovar Typhimurium strains are difficult to select in the absence of AcrB and TolC. Antimicrob Agents Chemother 50: 38-42.
26. Yan M, Sahin O, Lin J, Zhang Q (2006) Role of the CmeABC efflux pump in the emergence of fluoroquinolone-resistant Campylobacter under selection pressure. J Antimicrob Chemother 58: 1154-1159.
27. Tenover FC, Arbeit RD, Goering RV, Mickelsen PA, Murray BE, et al. (1995) Interpreting chromosomal DNA restriction patterns produced by pulsed field gel electrophoresis: criteria for bacterial strain typing. J Clin Microbiol 33: 2233-2239.
28. Dumarche P, De Champs C, Sirot D, Chanal C, Bonnet R, et al. (2002) TEM derivative-producing Enterobacter aerogenes strains: dissemination of a prevalent clone. Antimicrob Agents Chemother 46: 1128-1131.
29. Hasdemir UO, Chevalier J, Nordmann P, Pagès J-M (2004) Detection and prevalence of active drug efflux mechanism in various multidrug- resistant Klebsiella pneumoniae strains from Turkey. J Clin Microbiol 42: 2701-2706.
30. Ghisalberti D, Masi M, Pagès J-M, Chevalier J (2005) Chloramphenicol and expression of multidrug efflux pump in Enterobacter aerogenes. Biochem Biophys Res Commun 328: 1113-1118.
31. Viveiros M, Dupont M, Rodrigues L, Couto I, Davin-Régli A, Martins M, Pagès J-M, Amaral L (2007) Antibiotic stress, genetic response and altered permeability of E. coli. PLoS ONE Apr 11; 2(4): e365.
32. Ruiz N, Kahne D, Silhavy TJ (2006) Advances in understanding bacterial outer membrane biogenesis. Nat Rev Microbiol 4: 57-66.
33. Masi M, Pagès J-M, Pradel E (2006) Production of the cryptic EefABC efflux pump in Enterobacter aerogenes chloramphenicol-resistant mutants. J Antimicrob Chemother 57: 1223-1226.
34. Chollet R, Chevalier J, Bryskier A, Pagès J-M (2004) The AcrAB-TolC pump is involved in macrolide resistance but not in telithromycin efflux in Enterobacter aerogenes and Escherichia coli. Antimicrob Agents Chemother 48: 3621-3624.
35. George AM (1996) Multidrug resistance in enteric and other gram-negative bacteria. FEMS Microbiol Letters 139: 1-10.
36. Aeschlimann JR (2003) The role of multidrug efflux pumps in the antibiotic resistance of Pseudomonas aeruginosa and other gram-negative bacteria. Insights from the Society of Infectious Diseases Pharmacists. Pharmacotherapy 23: 916-924.
37. Mazzariol A, Zuliani J, Cornaglia G, Rossolini GM, Fontana R (2002) AcrAB efflux systems: expression and contribution to fluoroquinolone resistance in Klebsiella spp. Antimicrob Agents Chemother 12: 3984-3986.
38. Lomovskaya O, Bostian KA (2006) Practical applications and feasibility of efflux pump inhibitors in the clinic-a vision for applied use. Biochem Pharmacol 71: 910-918.
39. Saenz Y, Ruiz J, Zaraazaga M, Teixido M, Torres C, et al. (2004) Effect of the efflux pump inhibitor Phe-Arg-beta-naphthylamide on the MIC values of the quinolones, tetracycline and chloramphenicol, in Escherichia coli isolates of different origin. J Antimicrob Chemother 53: 544-545.
40. Quale J, Bratu S, Gupta J, Landman D (2006) Interplay of efflux system, ampC, and oprD expression in carbapenem resistance of Pseudomonas aeruginosa clinical isolates. Antimicrob Agents Chemother 50: 1623-1641.
41. Saito R, Sato K, Kutima W, Inami N, Nishiyama H, et al. (2006) Role of type II topoisomerase mutations and AcrAB efflux pump in fluoroquinolone-resistant clinical isolates of Proteus mirabilis. J antimicrob Chemother 58: 673-677.
42. Braibant M, Chevalier J, Chaslus-Dancla E, Pagès J-M, Cloeckaert A (2005) Structural and functional study of the phenicol-specific efflux pump FloR belonging to the Major Facilitator Superfamily. Antimicrob Agents Chemother 49: 2965-2971.
43. Bernstein C, Berstein H, Payne CM, Beard SE, Schneider J (1999) Bile salt activation of stress response promoters in Escherichia coli. Curr Microbiol 39: 68-72.
44. Russel AD (2003) Biocide use and antibiotic resistance: the relevance of laboratory findings to clinical and environmental situations. Lancet Infect Dis 3: 794-803.
45. Poole K (2008) Bacterial multidrug efflux pumps serve other functions. Microbe 3: 179-185.
46. Piddock LJ (2007) Multidrug-resistance efflux pumps - not just for resistance. Nat Rev Microbiol 4: 629-636.
47. Goosens H, Ferech M, Vander Stichele R, Elseviers M, for the ESAC Project Group (2005) Outpatient antibiotic use in Europe and association with resistance: a cross-national database study. Lancet 365: 579-587.
48. Ferech M, Coenen S, Malhotra-Kumar S, Dvorakova K, Hendrickx E, et al. (2006) European surveillance of antimicrobial consumption (ESAC): outpatient quinolone use in Europe. J Antimicrobial Chemother 58: 423-427.
49. EARSS Annual reports 2006. http://www.rivm.nl/earss/result/.
50. Machado E, Coque TM, Cantón R, Novais A, Sousa JC, Baquero F, Peixe L, Portuguese Resistance Study Group (2007) High diversity of extended-spectrum beta-lactamases among clinical isolates of Enterobacteriaceae from Portugal. J Antimicrob Chemother 60: 1370-1374.
51. Buckley AM, Webber MA, Cooles S, Randall LP, La Ragione RM, et al. (2006) The AcrAB-TolC efflux system of Salmonella enterica serovar Typhimurium plays a role in pathogenesis. Cell Microbiol 8: 847-856.
52. Warner DM, Folster JP, Shafer WM, Jerse AE (2008) Regulation of the MtrC-MtrD-MtrE efflux-pump system modulates the in vivo fitness of Neisseria gonorrhoeae. J Infect Dis 196: 1804-1812.
53. Lavigne JP, Bouzigues N, Chanal C, Mahamat A, Michaux-Charachon S, et al. (2004) Molecular epidemiology of Enterobacteriaceae isolates producing extended-spectrum β-lactamases in a French hospital. J Clin Microbiol 42: 3805-3808.